Ftse Mib
33.523,40
-0,55%
DAX
18.150,19
-0,07%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
0,00%
Bitcoin
61.389,80
-0,68%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Imago BioSciences Inc (IMGO) Imago BioSciences Inc (IMGO) Notizie

IMGO

Imago BioSciences (IMGO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMGO
DataOraFonteTitoloSimboloCompagnia
14/02/202314:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGOImago BioSciences Inc
23/01/202313:26Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:IMGOImago BioSciences Inc
17/01/202312:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IMGOImago BioSciences Inc
12/01/202322:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IMGOImago BioSciences Inc
11/01/202322:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGOImago BioSciences Inc
11/01/202316:42Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:IMGOImago BioSciences Inc
11/01/202315:25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGOImago BioSciences Inc
11/01/202315:19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:IMGOImago BioSciences Inc
11/01/202315:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGOImago BioSciences Inc
11/01/202314:58Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:IMGOImago BioSciences Inc
11/01/202314:51Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:IMGOImago BioSciences Inc
20/12/202222:05GlobeNewswire Inc.Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in MyelofibrosisNASDAQ:IMGOImago BioSciences Inc
12/12/202217:30GlobeNewswire Inc.Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022NASDAQ:IMGOImago BioSciences Inc
12/12/202216:00GlobeNewswire Inc.Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022NASDAQ:IMGOImago BioSciences Inc
12/12/202214:22Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:IMGOImago BioSciences Inc
12/12/202212:54Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:IMGOImago BioSciences Inc
12/12/202212:45Business WireMerck Begins Tender Offer to Acquire Imago BioSciences, Inc.NASDAQ:IMGOImago BioSciences Inc
30/11/202222:05GlobeNewswire Inc.Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid LeukemiaNASDAQ:IMGOImago BioSciences Inc
22/11/202212:30TipRanksAnalysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Imago BioSciences (IMGO)NASDAQ:IMGOImago BioSciences Inc
21/11/202223:24Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:IMGOImago BioSciences Inc
21/11/202220:35Dow Jones NewsTrending: Merck to Acquire Imago BioSciences for $1.35 BillionNASDAQ:IMGOImago BioSciences Inc
21/11/202216:32Dow Jones NewsImago BioSciences Shares Take Flight on Takeover by MerckNASDAQ:IMGOImago BioSciences Inc
21/11/202215:16Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:IMGOImago BioSciences Inc
21/11/202213:47TipRanksMerck Snaps Up Imago for $1.35 BillionNASDAQ:IMGOImago BioSciences Inc
21/11/202213:29Dow Jones NewsMerck to Buy Imago for $36 A Share, More Than Double Friday's CloseNASDAQ:IMGOImago BioSciences Inc
21/11/202212:45Business WireMerck to Acquire Imago BioSciences, Inc.NASDAQ:IMGOImago BioSciences Inc
11/11/202212:26TipRanksImago BioSciences (IMGO) Receives a Buy from H.C. WainwrightNASDAQ:IMGOImago BioSciences Inc
09/11/202222:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGOImago BioSciences Inc
09/11/202222:05GlobeNewswire Inc.Imago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business UpdatesNASDAQ:IMGOImago BioSciences Inc
07/11/202222:05GlobeNewswire Inc.Imago BioSciences to Participate in Upcoming Investor ConferencesNASDAQ:IMGOImago BioSciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMGO

La tua Cronologia

BIT
UCG
Unicredit
BIT
SPM
Saipem
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
FCT
Fincantieri
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
FCTAAW
Fincantieri
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network